Skip to main content
Log in

Therapy

Positioning of dilation in eosinophilic oesophagitis

  • News & Views
  • Published:

From Nature Reviews Gastroenterology & Hepatology

View current issue Sign up to alerts

Eosinophilic oesophagitis (EoE) is a clinicopathological condition. In addition to drugs and diets, dilation is an established treatment modality. Although the procedure was once considered risky, results from a new study add to the evidence that oesophageal dilation can be considered a safe and effective intervention to relieve dysphagia, the primary symptom of EoE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Proposed treatment algorithm for EoE.

References

  1. Attwood, S. E., Smyrk, T. C., Demeester, T. R. & Jones, J. B. Esophageal eosinophilia with dysphagia, a distinct clinicopathologic syndrome. Dig. Dis. Sci. 38, 109–116 (1993).

    Article  CAS  PubMed  Google Scholar 

  2. Straumann, A., Spichtin, H. P., Bernoulli, R., Loosli, J. & Voegtlin, J. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings [German]. Schweiz. Med. Wochenschr. 124, 1419–1429 (1994).

    CAS  PubMed  Google Scholar 

  3. Furuta, G. T. & Katzka, D. A. Eosinophilic esophagitis. N. Engl. J. Med. 373, 1640–1648 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hirano, I. Dilation in eosinophilic esophagitis: to do or not to do? Gastrointest. Endosc. 71, 713–714 (2010).

    Article  PubMed  Google Scholar 

  5. Moawad, F. J., Cheatham, J. G. & deZee, K. J. Meta-analysis: the safety and efficacy of dilation in eosinophilic esophagitis. Aliment. Pharmacol. Ther. 38, 713–720 (2013).

    Article  CAS  PubMed  Google Scholar 

  6. Schoepfer, A. M. et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety and impact on the underlying inflammation. Am. J. Gastroenterol. 105, 1062–1070 (2010).

    Article  PubMed  Google Scholar 

  7. Runge, T. M. et al. Outcomes of esophageal dilation in eosinophilic esophagitis: safety, efficacy, and persistence of the fibrostenotic phenotype. Am. J. Gastroenterol. http://dx.doi.org/10.1038/ajg.2015.399 (2016).

  8. Hirano, I. & Aceves, S. S. Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis. Gastroenterol. Clin. North Am. 43, 297–311 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Schoepfer, A. M. et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology 145, 1230–1236 (2013).

    Article  PubMed  Google Scholar 

  10. Richter, J. E. Esophageal dilation in eosinophilic esophagitis. Best Pract. Res. Clin. Gastroenterol. 29, 815–828 (2015).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alex Straumann.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Straumann, A., Schoepfer, A. Positioning of dilation in eosinophilic oesophagitis. Nat Rev Gastroenterol Hepatol 13, 192–194 (2016). https://doi.org/10.1038/nrgastro.2016.38

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2016.38

  • Springer Nature Limited

Navigation